GB-267

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameGB-267
Drug Alias NameGB267
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnti-CD3Anti-BCMAAnti-GPRC5D
TargetsT cell surface glycoprotein CD3B-cell maturation proteinG-protein coupled receptor family C group 5member D
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGenor Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGenor Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A